Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Τεστ Διαλογής Κατάχρησης Ουσιών× | Εργαλείο Αξιολόγησης Πόνου (Brief Pain Inventory)× | |
|---|---|---|
| Πεδίο | Υπηρεσίες Υγείας | Υπηρεσίες Υγείας |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 1982 | 1994 |
| Δημιουργός≠ | Harvey A. Skinner | Charles S. Cleeland and Kathryn M. Ryan |
| Τύπος≠ | Ten-item substance abuse screening instrument | Pain severity and interference measurement |
| Θεμελιώδης πηγή≠ | Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363-371. DOI ↗ | Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine Singapore, 23(2), 129-138. link ↗ |
| Εναλλακτικές ονομασίες | DAST-10, DAST | BPI, BPI-SF |
| Συναφείς | 3 | 3 |
| Σύνοψη≠ | The Drug Abuse Screening Test (DAST) is a brief, validated self-report instrument developed by Skinner in 1982 to screen for drug abuse and dependence in medical and psychiatric populations. The 10-item DAST-10 comprises yes/no questions assessing drug use patterns, consequences, and interference with life functioning. It is widely used in primary care, emergency medicine, and substance abuse treatment settings for rapid identification of individuals requiring further substance abuse evaluation. | The Brief Pain Inventory (BPI) is a concise, validated self-report instrument developed by Cleeland and Ryan beginning in 1994 to measure the severity and functional impact of pain in patients with cancer and chronic pain conditions. The BPI-Short Form comprises 11 items assessing pain severity and interference with daily activities, enabling rapid multidimensional pain assessment across diverse clinical populations. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|